FluidForm Bio successfully demonstrates advancements in engineered heart tissues with FRESH™ 3D bioprinting

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting.

Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

September 8, 2023

Telehealth Improves Hepatitis C Treatment in Patients With Opioid Use Disorder

Facilitated telemedicine integrated into an opioid treatment program led to better hepatitis C virus (HCV) cure rates compared with usual referral-based care, a randomized clinical

April 4, 2024

Opinion | The Goldilocks Dilemma: Too Much, Too Little, Just Right

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.